Effects of trolox, locally applied on round windows, on cisplatin-induced ototoxicity in guinea pigs

Int J Pediatr Otorhinolaryngol. 2003 Feb;67(2):133-9. doi: 10.1016/s0165-5876(02)00353-1.

Abstract

Objective: Cisplatin (CDDP), an antitumor agent widely used in the treatment of pediatric solid tumors, has dose-limiting side effects such as ototoxicity and nephrotoxicity. Recently, evidence has been accumulated to demonstrate that these side effects are closely related to oxidative stress. In the present study, we attempted to suppress CDDP-induced ototoxicity in guinea pigs by administering trolox, a water-soluble analogue of alpha-tocopherol which is a natural lipid-soluble antioxidant, locally on round windows.

Methods: Hartley albino guinea pigs (250-300 g) were treated with CDDP (0.3 mg/ml) in the presence or absence of a combined treatment of trolox (5 mM). Both drugs were administered locally on round windows.

Results: The combined treatment of trolox distinctly improved the ototoxic side effects induced by CDDP. These were: elevation of auditory brain stem response threshold at 4, 8 and 16 kHz and substantial losses of outer hair cells with the base-to-apex gradient.

Conclusion: Trolox, locally applied on round windows, showed a suppression on CDDP-ototoxicity. The results obtained in the present study suggest that a local application of trolox in the tympanic cavity can be a promising candidate to prevent the CDDP-ototoxicity in the future.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Analysis of Variance
  • Animals
  • Antioxidants / pharmacology*
  • Auditory Threshold
  • Chromans / pharmacology*
  • Cisplatin / adverse effects*
  • Cisplatin / pharmacology*
  • Disease Models, Animal
  • Drug Interactions
  • Ear, Middle / drug effects
  • Evoked Potentials, Auditory, Brain Stem
  • Female
  • Guinea Pigs
  • Hearing Loss, Sensorineural / chemically induced*
  • Hearing Loss, Sensorineural / drug therapy*
  • Probability
  • Random Allocation
  • Reference Values
  • Risk Assessment
  • Round Window, Ear / drug effects
  • Sensitivity and Specificity
  • Treatment Outcome

Substances

  • Antioxidants
  • Chromans
  • Cisplatin
  • 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid